Senseonics Revenue and Competitors

Claim your profile



Total Funding

Estimated Revenue & Valuation

  • Senseonics's estimated annual revenue is currently $36.1M per year.(i)
  • Senseonics received $149.5M in venture funding in July 2018.
  • Senseonics's estimated revenue per employee is $265,765
  • Senseonics's total funding is $455.5M.

Employee Data

  • Senseonics has 136 Employees.(i)
  • Senseonics grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life. The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

keywords:Biotechnology,Hardware,Healthcare,Medical Devices,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Senseonics News

2022-04-20 - Zacks: Analysts Anticipate Senseonics Holdings, Inc. (NYSE:SENS ...

Zacks: Analysts Anticipate Senseonics Holdings, Inc. (NYSE:SENS) Will Announce Quarterly Sales of $2.14 Million. Posted by admin on Apr 23rd,...

2022-04-06 - Senseonics Announces the First Patient Implant of the Eversense E3 ...

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed...

2022-04-06 - Senseonics Launches Eversense, but Is Dexcom's G7 Far Behind?

Senseonics Holdings has launched the Eversense E3 continuous glucose monitoring and has announced the first commercial implant of the device.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Senseonics Funding

DateAmountRoundLead InvestorsReference
2011-11-02$54.0MDDelphi VenturesArticle
2014-08-20$10.0MUndisclosedOxford Finance LLCArticle
2016-07-08$30.0MUndisclosedOxford Finance LLCArticle
2017-05-29$41.0MUndisclosedLeerink Partners LLCArticle
2017-08-21$28.8MUndisclosedNational Securities CorporationArticle